- Revenue Cycle Management
- COVID-19
- Reimbursement
- Diabetes Awareness Month
- Risk Management
- Patient Retention
- Staffing
- Medical Economics® 100th Anniversary
- Coding and documentation
- Business of Endocrinology
- Telehealth
- Physicians Financial News
- Cybersecurity
- Cardiovascular Clinical Consult
- Locum Tenens, brought to you by LocumLife®
- Weight Management
- Business of Women's Health
- Practice Efficiency
- Finance and Wealth
- EHRs
- Remote Patient Monitoring
- Sponsored Webinars
- Medical Technology
- Billing and collections
- Acute Pain Management
- Exclusive Content
- Value-based Care
- Business of Pediatrics
- Concierge Medicine 2.0 by Castle Connolly Private Health Partners
- Practice Growth
- Concierge Medicine
- Business of Cardiology
- Implementing the Topcon Ocular Telehealth Platform
- Malpractice
- Influenza
- Sexual Health
- Chronic Conditions
- Technology
- Legal and Policy
- Money
- Opinion
- Vaccines
- Practice Management
- Patient Relations
- Careers
Forms of fear; the season for sneezin’; a better coronavirus vaccine – Morning Medical Update
The top news stories in medicine today.
© batuhan toker - stock.adobe.com
Fear can be healthy when it helps people avoid danger. But prolonged, generalized fear can lead to debilitating anxiety disorders. Researchers are studying chemical and neural brain reactions that lead to generalized fear, which could in turn create new treatment methods for conditions such as post-traumatic stress disorder. Check out this explanation by Monica M. Bertagnolli, MD, director of the National Institutes of Health.
April showers bring May flowers, eventually. The U.S. Food and Drug Administration has this primer on the best medicines to counter the sneezing, itchy eyes and sinus pressure when freshly blooming plants unload pollen into the air. It’s a helpful refresher and the information can be shared with patients.
Vaccines against COVID-19 were a massive innovation, but annually updating boosters is inefficient for scientists, physicians and patients. Researchers said they have developed a new vaccine with broad protection against SARS-CoV-2 variants and members of the SARS Betacoronavirus subfamily. Read more in this study and accompanying news release.
